CorMedix Operating Income from 2010 to 2026
| CRMD Stock | USD 7.03 0.05 0.71% |
Operating Income | First Reported 2008-12-31 | Previous Quarter 19.5 M | Current Value 51.3 M | Quarterly Volatility 9.2 M |
Check CorMedix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CorMedix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 292.7 K, Interest Expense of 31.1 K or Selling General Administrative of 36.2 M, as well as many indicators such as Price To Sales Ratio of 11.98, Dividend Yield of 0.0179 or PTB Ratio of 5.32. CorMedix financial statements analysis is a perfect complement when working with CorMedix Valuation or Volatility modules.
CorMedix | Operating Income | Build AI portfolio with CorMedix Stock |
Analyzing CorMedix's Operating Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Income has evolved provides context for assessing CorMedix's current valuation and future prospects.
Latest CorMedix's Operating Income Growth Pattern
Below is the plot of the Operating Income of CorMedix over the last few years. Operating Income is the amount of profit realized from CorMedix operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of CorMedix is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. CorMedix's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CorMedix's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
CorMedix Operating Income Regression Statistics
| Arithmetic Mean | (20,645,877) | |
| Coefficient Of Variation | (58.98) | |
| Mean Deviation | 9,273,130 | |
| Median | (21,126,788) | |
| Standard Deviation | 12,177,843 | |
| Sample Variance | 148.3T | |
| Range | 45.9M | |
| R-Value | (0.69) | |
| Mean Square Error | 83.8T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | (1,654,239) | |
| Total Sum of Squares | 2372.8T |
CorMedix Operating Income History
Other Fundumenentals of CorMedix
CorMedix Operating Income component correlations
Click cells to compare fundamentals
About CorMedix Financial Statements
CorMedix stakeholders use historical fundamental indicators, such as CorMedix's Operating Income, to determine how well the company is positioned to perform in the future. Although CorMedix investors may analyze each financial statement separately, they are all interrelated. For example, changes in CorMedix's assets and liabilities are reflected in the revenues and expenses on CorMedix's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CorMedix. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | -20.1 M | -21.1 M | |
| Non Operating Income Net Other | -26.3 K | -27.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:Check out the analysis of CorMedix Correlation against competitors. For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Pharmaceuticals sector continue expanding? Could CorMedix diversify its offerings? Factors like these will boost the valuation of CorMedix. Projected growth potential of CorMedix fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CorMedix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 2.21 | Revenue Per Share | Quarterly Revenue Growth 8.102 | Return On Assets | Return On Equity |
CorMedix's market price often diverges from its book value, the accounting figure shown on CorMedix's balance sheet. Smart investors calculate CorMedix's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CorMedix's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CorMedix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CorMedix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.